Humanized FcRn mice – mice deficient for mouse FcRn ... Roopenian DC. 2012. Monoclonal antibodies directed against human FcRn and their applications. MAbs 4:208-16. PMID: 22453095.

At the 2024 Annual Meeting of the Society for Immunotherapy of Cancer (SITC 2024), held in Houston, USA, from , Akeso Biopharma (9926. HK) presented the mechanism of action (MOA) research findings of ...

Recent advancements in monoclonal antibody engineering are reshaping disease treatment, focusing on safety, effectiveness, ...

CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that ...

A new single-dose treatment demonstrates potential for improving heart repair following heart attacks in preclinical studies. Researchers at the Eli and Edythe Broad Center of Regenerative Medicine an ...

Approval based on Phase 3 data showing significantly more children aged 1 to 11 years on Dupixent achieved histological <a target=_blank ...

It is hoped that by coupling trastuzumab (Herceptin; Genentech/Roche) — a humanized monoclonal antibody ... Also, some of the antibodies were of mouse origin [and caused increased rates of ...

The Ebola virus disease outbreak now ravaging parts of West Africa is the largest on record. In fact, West Africa has seen more cases of the disease in 2014 than have been seen in all other ...

The scientists previously developed a drug, a therapeutic monoclonal ... in mice, to protect from multiple sclerosis and Alzheimer's, and to treat neurological effects of COVID-19. A humanized ...

who showed in skin biopsies from mice that MMP12 is mainly produced by M2 macrophages ... As previously reported, treatment of AD patients with dupilumab, a humanized monoclonal IgG4 antibody that ...